A Longitudinal Study of Adult Patients with Staphylococcus aureus Bacteremia over 11 Years in Korea
- PMID: 33904260
- PMCID: PMC8076844
- DOI: 10.3346/jkms.2021.36.e104
A Longitudinal Study of Adult Patients with Staphylococcus aureus Bacteremia over 11 Years in Korea
Abstract
Background: The temporal changes in the Staphylococcus aureus genotypes causing S. aureus bacteremia (SAB) and the corresponding clinical changes over the last decade in South Korea are rarely investigated.
Methods: A longitudinal study of adult SAB patients was conducted in a large referral hospital in Seoul, South Korea. Adult monomicrobial SAB patients were enrolled between August 2008 and December 2018. Genotyping was performed by multilocus sequence typing (MLST) and staphylococcal protein A (spa) typing. Trends in changes were identified by linear regression analysis.
Results: Of 1782 adult SAB patients, the blood isolates of 1,778 (99.8%) and 1,634 (91.7%) were determined to be MLST and spa type, respectively. ST5 (-2.626%/year) and ST239 (-0.354%/year) decreased during the study period (P < 0.001 for both), but ST72 (2.009%/yr)-and ST8 (0.567%/yr) increased (P < 0.001 for both). The most common genotype was changed from ST5 in 2008 (44.9%) to ST72 in 2018 (36.3%). Panton-Valentine leukocidin-positive spa-t008-MRSA (USA300) was found in 28.6%. Central venous catheter (CVC)-related SAB (-2.440%/yr) and persistent SAB (-1.016%/yr) decreased, but mortality and recurrence rates were unchanged.
Conclusion: Over the last decade, the hospital clones ST5 and ST239 have been replaced by community genotype ST72. This was associated with decreased CVC-related and persistent SAB. Increased USA300 was observed in community and hospital settings. Further research is required to identify the reasons for the ST72 epidemic and predict the impending epidemic of ST8 strains, including USA300.
Keywords: Bacteremia; Genotype; Multilocus Sequence Typing; Staphylococcus aureus.
© 2021 The Korean Academy of Medical Sciences.
Conflict of interest statement
The authors have no potential conflicts of interest to disclose.
Figures



Similar articles
-
Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study.Clin Infect Dis. 2019 Nov 13;69(11):1868-1877. doi: 10.1093/cid/ciz112. Clin Infect Dis. 2019. PMID: 31001618 Free PMC article.
-
Molecular epidemiology of Staphylococcus aureus bacteremia in a single large Minnesota medical center in 2015 as assessed using MLST, core genome MLST and spa typing.PLoS One. 2017 Jun 2;12(6):e0179003. doi: 10.1371/journal.pone.0179003. eCollection 2017. PLoS One. 2017. PMID: 28575112 Free PMC article.
-
Impact of Community-Onset Methicillin-Resistant Staphylococcus aureus on Staphylococcus aureus Bacteremia in a Central Korea Veterans Health Service Hospital.Ann Lab Med. 2019 Mar;39(2):158-166. doi: 10.3343/alm.2019.39.2.158. Ann Lab Med. 2019. PMID: 30430778 Free PMC article.
-
Clinical Management of Staphylococcus aureus Bacteremia in Neonates, Children, and Adolescents.Pediatrics. 2020 Sep;146(3):e20200134. doi: 10.1542/peds.2020-0134. Epub 2020 Aug 5. Pediatrics. 2020. PMID: 32759380
-
Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice.Clin Infect Dis. 2023 Nov 30;77(11):e57-e68. doi: 10.1093/cid/ciad500. Clin Infect Dis. 2023. PMID: 37950887 Free PMC article. Review.
Cited by
-
Genotypes of Staphylococcus aureus Clinical Isolates Are Associated with Phenol-Soluble Modulin (PSM) Production.Toxins (Basel). 2022 Aug 15;14(8):556. doi: 10.3390/toxins14080556. Toxins (Basel). 2022. PMID: 36006218 Free PMC article.
-
The molecular epidemiology and clinical implication of methicillin-resistant Staphylococcus aureus (MRSA) sequence types in pediatric bacteremia: a restrospective observational study, 2016-2021.BMC Infect Dis. 2024 Feb 24;24(1):259. doi: 10.1186/s12879-023-08914-5. BMC Infect Dis. 2024. PMID: 38402154 Free PMC article.
-
Clinical impact of and microbiological risk factors for qacA/B positivity in ICU-acquired ST5-methicillin-resistant SCCmec type II Staphylococcus aureus bacteremia.Sci Rep. 2022 Jul 6;12(1):11413. doi: 10.1038/s41598-022-15546-3. Sci Rep. 2022. PMID: 35794229 Free PMC article.
-
Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections.Yonsei Med J. 2022 Jul;63(7):611-618. doi: 10.3349/ymj.2022.63.7.611. Yonsei Med J. 2022. PMID: 35748072 Free PMC article.
-
Thirty-Day Mortality of Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Insights from a Retrospective Cohort Study.Yonsei Med J. 2024 Dec;65(12):770-776. doi: 10.3349/ymj.2023.0600. Yonsei Med J. 2024. PMID: 39609092 Free PMC article.
References
-
- Holland TL, Fowler VG., Jr Epidemiology of Staphylococcus aureus bacteremia in adults. [Updated 2019]. [Accessed November 24, 2019]. https://www.uptodate.com.
-
- Kirby WM. Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci. Science. 1944;99(2579):452–453. - PubMed
-
- Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339(8):520–532. - PubMed
-
- Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis. 2006;42(5):647–656. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical